Role of Vitamin D in Psoriasis
Topical vitamin D analogues are highly effective and recommended as first-line therapy for mild to moderate psoriasis (up to 52 weeks), particularly when combined with corticosteroids, while oral vitamin D supplementation is NOT recommended as it does not improve psoriasis severity. 1
Topical Vitamin D: Strongly Recommended
Monotherapy Efficacy
Topical vitamin D analogues (calcipotriene/calcipotriol, calcitriol, tacalcitol, maxacalcitol) are Grade A recommended for long-term use up to 52 weeks for mild to moderate psoriasis 1. These agents work by inhibiting keratinocyte proliferation and enhancing differentiation, directly targeting the pathophysiology of psoriasis 1.
Combination Therapy: The Superior Approach
The most effective strategy combines vitamin D analogues with topical corticosteroids 1:
Calcipotriene 0.005% + betamethasone dipropionate 0.064%: In a 52-week study of 828 patients, 69-74% achieved clear or almost clear status versus only 27% with vehicle control (P < .001), with no serious adverse events including striae or HPA axis suppression 1
Combination products outperform monotherapy: While ultrapotent/potent corticosteroids alone outperform calcipotriene alone at 3-8 weeks, the combination of calcipotriene with betamethasone dipropionate is more efficacious than betamethasone monotherapy 1
Site-Specific Recommendations (Grade A-B)
- Scalp psoriasis: Calcipotriene foam or calcipotriene + betamethasone dipropionate gel for 4-12 weeks 1
- Facial psoriasis: Tacalcitol ointment or calcipotriene + hydrocortisone for 8 weeks (Grade B) 1
- Nail psoriasis: Vitamin D analogues + betamethasone dipropionate can reduce thickness, hyperkeratosis, and onycholysis 1
Practical Regimens (Grade B)
Two evidence-based maintenance strategies 1:
- Weekday/weekend split: Vitamin D analogues twice daily on weekdays + high-potency corticosteroids twice daily on weekends
- Morning/evening split: High-potency corticosteroids in morning + vitamin D analogues in evening
Critical Caveats for Topical Use
- Avoid salicylic acid: The acidic pH inactivates calcipotriene and reduces effectiveness 1
- Phototherapy timing: Apply vitamin D analogues AFTER phototherapy to avoid UVA inactivation and UVB blockage 1
- Onset of action: Efficacy typically noted at 8 weeks, not 4 weeks—set patient expectations accordingly 1
Oral Vitamin D: NOT Recommended
Oral vitamin D supplementation does not directly improve psoriasis disease activity at dosages that avoid hypercalcemia 1. This is a critical distinction from topical therapy.
The Evidence Against Oral Supplementation
Multiple recent meta-analyses and RCTs consistently show no benefit:
2023 meta-analysis (1876 psoriasis patients, 7532 controls): While psoriasis patients had significantly lower 25(OH)D levels (21.0 vs 27.3 ng/mL, p<0.00001), oral supplementation in 4 RCTs (173 patients vs 160 placebo) showed no significant PASI improvement at 3,6, or 12 months 2
2023 JAMA Dermatology RCT (highest quality recent study): 122 patients with baseline 25(OH)D <24 ng/mL randomized to vitamin D (100,000 IU loading, then 20,000 IU/week) vs placebo for 4 months. Despite raising 25(OH)D to 29.7 ng/mL, there was no significant difference in PASI change (adjusted difference 0.11,95% CI -0.23 to 0.45) 3
2021 meta-analysis: After Hartung-Knapp adjustment, results became non-significant (MD -0.92,95% CI -2.21 to 0.38) 4
Why the Discrepancy Between Topical and Oral?
Topical vitamin D analogues work through direct local immunomodulation of keratinocytes and T-cells in psoriatic plaques 5. Oral supplementation, even when correcting systemic deficiency, does not achieve the same local tissue concentrations or direct anti-proliferative effects at dosages that avoid hypercalcemia 1.
Patient Counseling Point
Many patients ask about oral vitamin D for skin health. Redirect them to topical vitamin D therapy, which is proven effective 1. While correcting vitamin D deficiency for general health is reasonable, it should not be expected to improve psoriasis severity.
Algorithmic Approach
For mild to moderate psoriasis:
- First-line: Topical vitamin D analogue + potent corticosteroid combination product (Grade A)
- Maintenance: Consider weekday vitamin D/weekend corticosteroid regimen to minimize steroid adverse effects (Grade B)
- Scalp involvement: Use foam or gel formulations for 4-12 weeks (Grade A)
- Facial involvement: Use calcipotriene + hydrocortisone for 8 weeks (Grade B)
- If using phototherapy: Apply vitamin D analogues AFTER light treatment
- Do NOT recommend oral vitamin D supplementation for psoriasis improvement
Common pitfall: Patients may confuse the proven efficacy of topical vitamin D with oral supplementation—these are entirely different interventions with different outcomes. The evidence strongly supports topical but not oral use 1, 2, 3.